Chronic myelogenous leukemia epidemiology and demographics

	Chronic myelogenous leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chronic myelogenous leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chronic myelogenous leukemia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chronic myelogenous leukemia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chronic myelogenous leukemia epidemiology and demographics
CDC on Chronic myelogenous leukemia epidemiology and demographics
Chronic myelogenous leukemia epidemiology and demographics in the news
Blogs on Chronic myelogenous leukemia epidemiology and demographics
Directions to Hospitals Treating Chronic myelogenous leukemia
Risk calculators and risk factors for Chronic myelogenous leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

The incidence of Chronic Myeloid Leukemia (CML) was estimated to be 1–2 cases per 100,000 individuals worldwide. The peak age for the disease is 50 to 55. incidence in CML increases by age, at least up to 75–80 years. In children, CML is a very rare disease with an incidence of 0.6–1.2 million children/year. CML is more common in males than in females with male-to-female ratio varying between 1.2 and 1.7 in different studies. The gender difference in incidence is less prominent in younger age groups. myelogenous leukemia accounts for 15% of adult leukemias. although some series report a median age of up to 67 years.

PMID:24729196 /PMID:20221270/ PMID:25814090 /PMID:10428738

The peak age for the disease is 50 to 55.PMID:20221270The incidence in CML increases by age, at least up to 75–80 years. In children, CML is a very rare disease with an incidence of 0.6–1.2 million children/year [26].CML is more common in males than in females with male-to-female ratio varying between 1.2 and 1.7 in different studies [8, 20, 27]. The gender difference in incidence is less prominent in younger age groups.PMID:25814090Chronic myelogenous leukemia accounts for 15% of adult leukemias, has an incidence of 1 to 2 cases per 100000 population, and has a male-to-female ratio of 1.3 to 1. Incidence increases with age. The median age at presentation is 45 to 55 years, although some series report a median age of up to 67 years.PMID:10428738

Epidemiology

Incidence

^[1]

Age

Gender

^[1]

References

↑ ^1.0 ^1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WikiDoc Sources

[SEER-1] 1.0 ^1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

[1]